Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients
EHAB M. REYAD, M.D., P., H. MANSOUR, M.D., H. (2020). Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients. EKB Journal Management System, 88(September), 1655-1661. doi: 10.21608/mjcu.2020.116259
PHEBE L. ABDEL-MESSEIH, M.D.; EHAB M. REYAD, M.D.; HEBA H. MANSOUR, M.D.. "Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients". EKB Journal Management System, 88, September, 2020, 1655-1661. doi: 10.21608/mjcu.2020.116259
EHAB M. REYAD, M.D., P., H. MANSOUR, M.D., H. (2020). 'Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients', EKB Journal Management System, 88(September), pp. 1655-1661. doi: 10.21608/mjcu.2020.116259
EHAB M. REYAD, M.D., P., H. MANSOUR, M.D., H. Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients. EKB Journal Management System, 2020; 88(September): 1655-1661. doi: 10.21608/mjcu.2020.116259